All Stories

  1. Botanical and Upcycled Bioactives for Advanced Topical Formulations: Mechanistic Pathways, Cutaneous Delivery, and Sustainability-by-Design
  2. Rose petal-derived nanovesicles as a sustainable and functional ingredient for next-generation cosmetics
  3. Hybrid patch based on fast-dissolving electrospun nanocomposite membrane for local inflammation treatment
  4. Cosmetics for Sensitive Skin: Assessing Rheological Properties, Stability, and Safety
  5. Microfluidic Design of Ultradeformable Liposomes for Advanced Skin Delivery of Stellaria media Phytocomplex
  6. Assessing effectiveness of multistage nanomedicines for multidrug therapy of vitiligo
  7. Chlorella-enriched hydrogels protect against myocardial damage and reactive oxygen species production in an in vitro ischemia/reperfusion model using cardiac spheroids
  8. Antimicrobial Compounds from Food Waste in Cosmetics
  9. OX26-cojugated gangliosilated liposomes to improve the post-ischemic therapeutic effect of CDP-choline
  10. Olive Leaves and Citrus Peels: From Waste to Potential Resource for Cosmetic Products
  11. Gelled Liquid Crystal Nanocarriers for Improved Antioxidant Activity of Resveratrol
  12. Solid Lipid Nanoparticles Containing Morin: Preparation, Characterization, and Ex Vivo Permeation Studies
  13. Bicalutamide Anticancer Activity Enhancement by Formulation of Soluble Inclusion Complexes with Cyclodextrins
  14. Chitosan/Cyclodextrin Nanospheres for Potential Nose-to-Brain Targeting of Idebenone
  15. In Situ Swelling Formulation of Glycerol-Monooleate-Derived Lyotropic Liquid Crystals Proposed for Local Vaginal Application
  16. A comparison between silicone‐free and silicone‐based emulsions: Technological features and in vivo evaluation
  17. Alginate-Based Composites for Corneal Regeneration: The Optimization of a Biomaterial to Overcome Its Limits
  18. Macrophage-Derived Extracellular Vesicles: A Promising Tool for Personalized Cancer Therapy
  19. Ammonium Glycyrrhizinate and Bergamot Essential Oil Co-Loaded Ultradeformable Nanocarriers: An Effective Natural Nanomedicine for In Vivo Anti-Inflammatory Topical Therapies
  20. Lyotropic Liquid Crystals: A Biocompatible and Safe Material for Local Cardiac Application
  21. Lipid-Based Formulations Containing Labrafil M2125-CS: A Deep Investigation on Nanosystem Stability
  22. Rutin-Loaded Nanovesicles for Improved Stability and Enhanced Topical Efficacy of Natural Compound
  23. Tendon Tissue Repair in Prospective of Drug Delivery, Regenerative Medicines, and Innovative Bioscaffolds
  24. Development of Chitosan/Cyclodextrin Nanospheres for Levofloxacin Ocular Delivery
  25. Positively Charged Lipid as Potential Tool to Influence the Fate of Ethosomes
  26. Radiopharmaceutical preparations: what are the legislative differences across Europe?
  27. Meglumine Antimoniate‐Loaded Aqueous‐Core PLA Nanocapsules: Old Drug, New Formulation against Leishmania ‐Related Diseases
  28. EtoGel for Intra-Articular Drug Delivery: A New Challenge for Joint Diseases Treatment
  29. Topical Unsaturated Fatty Acid Vesicles Improve Antioxidant Activity of Ammonium Glycyrrhizinate
  30. Nanonutraceuticals: The New Frontier of Supplementary Food
  31. Influence of Materials Properties on Bio-Physical Features and Effectiveness of 3D-Scaffolds for Periodontal Regeneration
  32. Rutin-Loaded Solid Lipid Nanoparticles: Characterization and In Vitro Evaluation
  33. Improvement of Ferulic Acid Antioxidant Activity by Multiple Emulsions: In Vitro and In Vivo Evaluation
  34. Oleuropein-Laded Ufasomes Improve the Nutraceutical Efficacy
  35. Targeting of the Pilosebaceous Follicle by Liquid Crystal Nanocarriers: In Vitro and In Vivo Effects of the Entrapped Minoxidil
  36. Design and Characterization of Glyceryl Monooleate-Nanostructures Containing Doxorubicin Hydrochloride
  37. Cardiac Stem Cell-Loaded Delivery Systems: A New Challenge for Myocardial Tissue Regeneration
  38. Vegetable-Milk-Based Yogurt-Like Structure: Rheological Properties Influenced by Gluten-Free Carob Seed Flour
  39. Ammonium glycyrrhizate skin delivery from ultradeformable liposomes: A novel use as an anti-inflammatory agent in topical drug delivery
  40. Influence of Various Model Compounds on the Rheological Properties of Zein-Based Gels
  41. Rutin-Loaded Poloxamer 407-Based Hydrogels for In Situ Administration: Stability Profiles and Rheological Properties
  42. The Rheolaser Master™ and Kinexus Rotational Rheometer® to Evaluate the Influence of Topical Drug Delivery Systems on Rheological Features of Topical Poloxamer Gel
  43. Poly(ethyl acrylate-co-methyl Methacrylate-co-trimethylammoniethyl methacrylate chloride) (Eudragit RS100) Nanocapsules as Nanovector Carriers for Phoenix dactylifera L. Seeds Oil: a Versatile Antidiabetic Agent
  44. Sulforaphane-Loaded Ultradeformable Vesicles as A Potential Natural Nanomedicine for the Treatment of Skin Cancer Diseases
  45. Development and In Vivo Evaluation of Multidrug Ultradeformable Vesicles for the Treatment of Skin Inflammation
  46. Physicochemical Characterization and Antioxidant Activity Evaluation of Idebenone/Hydroxypropyl-β-Cyclodextrin Inclusion Complex †
  47. Biogenic Amines, Phenolic, and Aroma-Related Compounds of Unroasted and Roasted Cocoa Beans with Different Origin
  48. Essential Oils-Loaded Polymer Particles: Preparation, Characterization and Antimicrobial Property
  49. Nanoformulation for potential topical delivery of Vismodegib in skin cancer treatment
  50. Polydocanol foam stabilized by liposomes: Supramolecular nanoconstructs for sclerotherapy
  51. Mathematical Models as Tools to Predict the Release Kinetic of Fluorescein from Lyotropic Colloidal Liquid Crystals
  52. Drug-Loaded Biocompatible Nanocarriers Embedded in Poloxamer 407 Hydrogels as Therapeutic Formulations
  53. Post-insertion parameters of PEG-derivatives in phosphocholine-liposomes
  54. Mathematical Models as Tools to Predict the Release Kinetic of Fluorescein from Monoglyceride Colloidal Liquid Crystals
  55. Mucosal Applications of Poloxamer 407-Based Hydrogels: An Overview
  56. Simultaneous quantification of Gemcitabine and Irinotecan hydrochloride in rat plasma by using high performance liquid chromatography-diode array detector
  57. An insight of in vitro transport of PEGylated non-ionic surfactant vesicles (NSVs) across the intestinal polarized enterocyte monolayers
  58. Sodium deoxycholate-decorated zein nanoparticles for a stable colloidal drug delivery system
  59. Innovative vesicles for dermal and transdermal drug delivery
  60. Characterization and in vitro anticancer properties of chitosan-microencapsulated flavan-3-ols-rich grape seed extracts
  61. Physicochemical characterization of pH-responsive and fusogenic self-assembled non-phospholipid vesicles for a potential multiple targeting therapy
  62. Interaction between PEG lipid and DSPE/DSPC phospholipids: An insight of PEGylation degree and kinetics of de-PEGylation
  63. Oleuropein Decreases Cyclooxygenase-2 and Interleukin-17 Expression and Attenuates Inflammatory Damage in Colonic Samples from Ulcerative Colitis Patients
  64. Anticancer activity of all- trans retinoic acid-loaded liposomes on human thyroid carcinoma cells
  65. pH-sensitive niosomes: Effects on cytotoxicity and on inflammation and pain in murine models
  66. Drug delivery in overcoming the blood–brain barrier: role of nasal mucosal grafting
  67. Improvement of Oral Bioavailability of Curcumin upon Microencapsulation with Methacrylic Copolymers
  68. Rutin-loaded chitosan microspheres: Characterization and evaluation of the anti-inflammatory activity
  69. Pharmacological effect of a new idebenone formulation in a model of carrageenan-induced inflammatory pain
  70. Microextraction by packed sorbent and HPLC–PDA quantification of multiple anti-inflammatory drugs and fluoroquinolones in human plasma and urine
  71. Preparation, characterization and photostability assessment of curcumin microencapsulated within methacrylic copolymers
  72. PDE5 Inhibitors-Loaded Nanovesicles: Physico-Chemical Properties and In Vitro Antiproliferative Activity
  73. Nanotherapeutics for anti-inflammatory delivery
  74. Cationic Supramolecular Vesicular Aggregates for Pulmonary Tissue Selective Delivery in Anticancer Therapy
  75. Niosomes as Drug Nanovectors: Multiscale pH-Dependent Structural Response
  76. Helicobacter pylori ATCC 43629/NCTC 11639 Outer Membrane Vesicles (OMVs) from Biofilm and Planktonic Phase Associated with Extracellular DNA (eDNA)
  77. Delivery of miR-34a by chitosan/PLGA nanoplexes for the anticancer treatment of multiple myeloma
  78. Influence of the Supramolecular Micro-Assembly of Multiple Emulsions on their Biopharmaceutical Features and In vivo Therapeutic Response
  79. HPLC–FLD and spectrofluorometer apparatus: How to best detect fluorescent probe-loaded niosomes in biological samples
  80. Determination of ciprofloxacin and levofloxacin in human sputum collected from cystic fibrosis patients using microextraction by packed sorbent-high performance liquid chromatography photodiode array detector
  81. Ultradeformable liposomes as multidrug carrier of resveratrol and 5-fluorouracil for their topical delivery
  82. Polyethylene glycol (PEG)-dendron phospholipids as innovative constructs for the preparation of super stealth liposomes for anticancer therapy
  83. Bisphosphonate–polyaspartamide conjugates as bone targeted drug delivery systems
  84. Aqueous-core PEG-coated PLA nanocapsules for an efficient entrapment of water soluble anticancer drugs and a smart therapeutic response
  85. Polyaspartamide-Doxorubicin Conjugate as Potential Prodrug for Anticancer Therapy
  86. Targeting the thyroid gland with thyroid-stimulating hormone (TSH)-nanoliposomes
  87. Physicochemical features and transfection properties of chitosan/poloxamer 188/poly(D,L-lactide-co-glycolide) nanoplexes
  88. Evaluation of anticancer activity of celastrol liposomes in prostate cancer cells
  89. A characterization study of resveratrol/sulfobutyl ether-β-cyclodextrin inclusion complex and in vitro anticancer activity
  90. Niosomes from 80s to present: The state of the art
  91. Ammonium glycyrrhizinate-loaded niosomes as a potential nanotherapeutic system for anti-inflammatory activity in murine models
  92. Anticancer activity of liposomal bergamot essential oil (BEO) on human neuroblastoma cells
  93. Liposomal chemotherapeutics
  94. Sustained Zero-Order Release of Intact Ultra-Stable Drug-Loaded Liposomes from an Implantable Nanochannel Delivery System
  95. Differential Scanning Calorimetry as a Tool to Investigate the Transfer of Anticancer Drugs to Biomembrane Model
  96. Gemcitabine-loaded biocompatible nanocapsules for the effective treatment of human cancer
  97. Interaction of pH-sensitive non-phospholipid liposomes with cellular mimetic membranes
  98. Anti-inflammatory activity of novel ammonium glycyrrhizinate/niosomes delivery system: Human and murine models
  99. Squalenoyl prodrug of paclitaxel: Synthesis and evaluation of its incorporation in phospholipid bilayers
  100. Folate-targeted supramolecular vesicular aggregates as a new frontier for effective anticancer treatment in in vivo model
  101. Improved in vitro and in vivo collagen biosynthesis by asiaticoside-loaded ultradeformable vesicles
  102. In vitro antimycoplasmal activity of citrus bergamia essential oil and its major components
  103. Low-Frequency Ultrasound in Medicine: An In Vivo Evaluation
  104. Self-assembled squalenoyl-cytarabine nanostructures as a potent nanomedicine for treatment of leukemic diseases
  105. Paclitaxel-loaded ethosomes®: Potential treatment of squamous cell carcinoma, a malignant transformation of actinic keratoses
  106. Gemcitabine and tamoxifen-loaded liposomes as multidrug carriers for the treatment of breast cancer diseases
  107. Gemcitabine-loaded innovative nanocarriers vs GEMZAR: Biodistribution, pharmacokinetic features andin vivoantitumor activity
  108. Lipophilic Hydroxytyrosol Esters: Fatty Acid Conjugates for Potential Topical Administration
  109. Ethosomes® and transfersomes® containing linoleic acid: physicochemical and technological features of topical drug delivery carriers for the potential treatment of melasma disorders
  110. Gemcitabine-loaded chitosan microspheres. Characterization and biological in vitro evaluation
  111. Supramolecular devices to improve the treatment of brain diseases
  112. Liposomes as multicompartmental carriers for multidrug delivery in anticancer chemotherapy
  113. Drug Delivery Applications with Ethosomes
  114. Folate-targeted supramolecular vesicular aggregates based on polyaspartyl-hydrazide copolymers for the selective delivery of antitumoral drugs
  115. Non-ionic surfactant vesicles in pulmonary glucocorticoid delivery: Characterization and interaction with human lung fibroblasts
  116. In Vitro Evaluation of the Activity of Gemcitabine-Loaded Pegylated Unilamellar Liposomes Against Papillary Thyroid Cancer Cells~!2010-04-18~!2010-06-27~!2010-08-23~!
  117. Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR®: Biodistribution, pharmacokinetic features and in vivo antitumor activity
  118. Nanoparticulate devices for brain drug delivery
  119. A novel animal model to evaluate the ability of a drug delivery system to promote the passage through the BBB
  120. Turbiscan Lab® Expert analysis of the stability of ethosomes® and ultradeformable liposomes containing a bilayer fluidizing agent
  121. Novel PEG-coated niosomes based on bola-surfactant as drug carriers for 5-fluorouracil
  122. Retinoids: new use by innovative drug-delivery systems
  123. In vivo activity of gemcitabine-loaded PEGylated small unilamellar liposomes against pancreatic cancer
  124. Lipoamino Acid Prodrugs of Paclitaxel: Synthesis and Cytotoxicity Evaluation on Human Anaplastic Thyroid Carcinoma Cells
  125. Colloidal carriers for the enhanced delivery through the skin
  126. Liposomal delivery improves the growth-inhibitory and apoptotic activity of low doses of gemcitabine in multiple myeloma cancer cells
  127. Innovative bola-surfactant niosomes as topical delivery systems of 5-fluorouracil for the treatment of skin cancer
  128. Improved In Vitro Anti-Tumoral Activity, Intracellular Uptake and Apoptotic Induction of Gemcitabine-Loaded Pegylated Unilamellar Liposomes
  129. In vitro skin permeation of sunscreen agents from O/W emulsions
  130. Innovative Drug Delivery Systems for the Administration of Natural Compounds
  131. In vitro and in vivo evaluation of Bola-surfactant containing niosomes for transdermal delivery
  132. Effects of Lipid Composition and Preparation Conditions on Physical-Chemical Properties, Technological Parameters and In Vitro Biological Activity of Gemcitabine-Loaded Liposomes
  133. In vitro antimycoplasmal activity of Melaleuca alternifolia essential oil
  134. Influence of modified cyclodextrins on solubility and percutaneous absorption of celecoxib through human skin
  135. Electrocortical effects of MDMA are potentiated by acoustic stimulation in rats
  136. Physico-chemical characterization of disoxaril–dimethyl-β-cyclodextrin inclusion complex and in vitro permeation studies
  137. Combined NMR-crystallographic and modelling investigation of the inclusion of molsidomine into α-, β- and γ-cyclodextrins
  138. Ethosomes for skin delivery of ammonium glycyrrhizinate: In vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers
  139. Preparation of celecoxib-dimethyl-β-cyclodextrin inclusion complex: characterization and in vitro permeation study
  140. Tolerability and improved protective action of idebenone‐loaded pegylated liposomes on ethanol‐induced injury in primary cortical astrocytes**Preliminary data were presented at the Second International Conference on New Biomedical Materials, 5–8 April ...
  141. Combining NMR and molecular modelling in a drug delivery context: investigation of the multi-mode inclusion of a new NPY-5 antagonist bromobenzenesulfonamide into β-cyclodextrin
  142. Synthesis, Characterization and In Vitro Evaluation of Dimethyl-β-cyclodextrin-4-biphenylylacetic Acid Conjugate
  143. Lecithin microemulsions for the topical administration of ketoprofen: percutaneous adsorption through human skin and in vivo human skin tolerability
  144. Ethanol-induced injury in rat primary cortical astrocytes involves oxidative stress: effect of idebenone
  145. Preparation, characterization, molecular modeling and In vitro activity of paclitaxel–cyclodextrin complexes
  146. In vitro and in vivo evaluation of caffeic and ferulic acids as topical photoprotective agents